Revenio Group Oyj (LON:0KFH)
22.30
0.00 (0.00%)
At close: Dec 18, 2025
Revenio Group Oyj Market Cap
Revenio Group Oyj has a market cap or net worth of 518.49 million as of December 29, 2025. Its market cap has decreased by -14.45% in one year.
Market Cap
518.49M
Enterprise Value
516.92M
Revenue
95.42M
Ranking
n/a
PE Ratio
32.11
Stock Price
22.30
Market Cap Chart
Since October 1, 2001, Revenio Group Oyj's market cap has increased from 8.52M to 518.49M, an increase of 5,987.02%. That is a compound annual growth rate of 18.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 520.47M | -11.20% |
| Dec 30, 2024 | 586.14M | -6.48% |
| Dec 29, 2023 | 626.76M | -31.13% |
| Dec 30, 2022 | 910.05M | -26.48% |
| Dec 30, 2021 | 1.24B | 2.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.05B |
| GSK plc | 72.45B |
| Haleon | 33.16B |
| Smith & Nephew | 10.37B |
| Convatec Group | 4.64B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 1.71B |
| HUTCHMED (China) | 1.69B |